-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/v2-menopausal-hormone-therapy-preventive-medicatio
May 09, 2005 - Harms include increased risk for venous thromboembolism (fair evidence), stroke (fair evidence), dementia … Other harms include increased risk for breast cancer (good evidence), venous thromboembolism (good evidence … For example, for combined estrogen and progestin, some risks (such as the risks for venous thromboembolism … The estrogen-only arm of the WHI trial showed a trend toward increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism .
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2002-2005
May 09, 2005 - Harms include increased risk for venous thromboembolism (fair evidence), stroke (fair evidence), dementia … Other harms include increased risk for breast cancer (good evidence), venous thromboembolism (good evidence … For example, for combined estrogen and progestin, some risks (such as the risks for venous thromboembolism … The estrogen-only arm of the WHI trial showed a trend toward increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism .
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9NcVWwGErrH9b9M_6NryW
May 01, 2005 - Other harms include increased risk for breast cancer (good evidence), venous
thromboembolism (good evidence … Harms include increased risk for venous thromboembolism (fair evidence), stroke (fair
evidence), dementia … The estrogen-only arm of the WHI trial showed a
trend toward increased risk for venous thromboembolism … Postmenopausal
estrogen replacement and risk for venous
thromboembolism: a systematic review and … Hormone
Replacement Therapy and Risk of Venous
Thromboembolism.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sQ7hREGwnBm8Wh-LEFWP4F
October 01, 2002 - Potential benefits of Hormone Replacement Therapy
Analytic Framework 1
Venous
thromboembolism
(DVT/PE … Venous thromboembolism (deep vein thrombosis
and pulmonary embolism)?
2. Breast cancer incidence? … Venous thromboembolism? … Hormone
Replacement Therapy and Risk of Venous
Thromboembolism. … Risk of
venous thromboembolism in users of hormone
replacement therapy.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/v1-breast-cancer-medications-for-risk-reduction--s
July 08, 2002 - incidence between the tamoxifen and placebo groups in this age group. 7 The relative risk increase in venous … thromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
July 08, 2002 - incidence between the tamoxifen and placebo groups in this age group. 7 The relative risk increase in venous … thromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism
-
www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/v2-menopausal-hormone-therapy-preventive-medicatio
August 21, 2002 - Although our review supports an association between HRT and increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism . … Hormone replacement therapy and risk of venous thromboembolism: a systematic review and meta-analysis … Risk of venous thromboembolism in users of hormone replacement therapy. … Venous thromboembolism?
-
www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
August 21, 2002 - Although our review supports an association between HRT and increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism . … Hormone replacement therapy and risk of venous thromboembolism: a systematic review and meta-analysis … Risk of venous thromboembolism in users of hormone replacement therapy. … Venous thromboembolism?
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
July 02, 2002 - incidence between the
tamoxifen and placebo groups in this age group.7
The relative risk increase in venous … thromboembolism from tamoxifen or raloxifene
appears similar to the risk for venous
thromboembolism
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
May 29, 2012 - Potential harms include coronary heart disease events; stroke; cognitive decline; venous thromboembolism … Potential harms include coronary heart disease events; stroke; cognitive decline; venous thromboembolism
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/G7CCbu64mf-nCynBkHbFLA
July 01, 2012 - Potential harms include coronary heart disease events; stroke; cognitive decline; venous thromboembolism
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
December 12, 2017 - thromboembolism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI … thromboembolism (21 more cases [95% CI, 12 to 33]). … thromboembolism ( Table 3 and Figure 3 ; Table 4 summarizes the strength of evidence). … thromboembolism (21 more cases per 10,000 patient-years [95% CI, 12 to 33]) were also statistically … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
December 12, 2017 - thromboembolism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI … thromboembolism (21 more cases [95% CI, 12 to 33]). … thromboembolism ( Table 3 and Figure 3 ; Table 4 summarizes the strength of evidence). … thromboembolism (21 more cases per 10,000 patient-years [95% CI, 12 to 33]) were also statistically … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
April 19, 2022 - progestin is associated with moderate harms, including increased risk of invasive breast cancer, stroke, venous … thromboembolism, dementia, gallbladder disease, and urinary incontinence. … evidence that use of estrogen alone is associated with moderate harms, including increased risk of stroke, venous … thromboembolism, gallbladder disease, and urinary incontinence.
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/hypertensive-disorders-pregnancy-screening
May 20, 2021 - infarction
Renal or hepatic injury/failure
Pulmonary edema, adult respiratory distress syndrome
Venous … thromboembolism (deep vein thrombosis/pulmonary embolism)
Disseminated intravascular coagulation
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertensive-disorders-pregnancy-screening
September 02, 2021 - infarction
Renal or hepatic injury/failure
Pulmonary edema, adult respiratory distress syndrome
Venous … thromboembolism (deep vein thrombosis/pulmonary embolism)
Disseminated intravascular coagulation
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
December 12, 2017 - thromboembolism, and a small to moderate harm of increased risk of coronary heart disease. … thromboembolism. … thromboembolism between women randomized to hormone therapy vs placebo over 2 to 3 years; however, the … thromboembolism b
21 (12 to 33)
Urinary incontinence
876 (606 to 1168)
Benefits … thromboembolism b
11 (3 to 22)
Urinary incontinence
1261 (880 to 1689)
Benefits
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
October 22, 2015 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Research Plan
Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions
October 22, 2015
Recommendations made by the USPSTF are indepen…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
November 01, 2022 - thromboembolism over 7.2 years (258 vs 181 cases; 77 more [95% CI, 19-153]), and urinary incontinence … thromboembolism (246 vs 126 cases; 120 more [95% CI, 68-185]) over 5.6 years; probable dementia (179 … thromboembolism ( Figure 3 ; strength of evidence reported in Table 2 ). … thromboembolism compared with those who received placebo (77 more cases per 10,000 persons over 7.2 … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
September 01, 2019 - difference no difference
Fractures
Cataracts
Endometrial Cancer
(cancer of the uterus)
Blood Clots
(venous … thromboembolism events)
* Only tamoxifen is approved for use in premenopausal women.
** Aromatase inhibitors